Tetherex raises $50M series B, plans Phase II for pan-selectin inhibitor

By Jennie Walters | Apr 18, 2018 | 9:14 PM GMT

Tetherex Pharmaceuticals Inc. (Oklahoma City, Okla.) said it closed a $50 million series B round Wednesday led by existing investor MPM Capital. I2E, Tetherex board member Philip

Read the full 271 word article

How to gain access

Continue reading with a
two-week free trial.